Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MHLW Releases New Drug Pricing Report Amid Deadlock In Price Revision Exemption Debate

This article was originally published in PharmAsia News

Executive Summary

Japan's Ministry of Health, Labor and Welfare submitted a status report on new drug pricing in 2008 to the Central Social Medical Insurance Agency, also called Chuikyo. The report showed that drug prices calculated by using similar drug methods were 10 percent lower than overseas average prices
Advertisement

Related Content

Could Japan's Chuikyo Embrace NICE Model As New Chairman Takes Reign?
Could Japan's Chuikyo Embrace NICE Model As New Chairman Takes Reign?
Japan To Lower Price Of Eight Drugs From Takeda, Novartis, BMS And Chugai By 12-18 Percent
Japan To Lower Price Of Eight Drugs From Takeda, Novartis, BMS And Chugai By 12-18 Percent
Hospital Physicians Slated To Gain In Japan's New Reimbursement Scheme
Hospital Physicians Slated To Gain In Japan's New Reimbursement Scheme
Japan To Experiment With New National Health Insurance Drug Pricing Policy In FY 2010
Japan To Experiment With New NHI Drug Pricing Policy In FY 2010
Generic Drug Use To Increase In Japan
Generic Drug Use To Increase In Japan
Advertisement
UsernamePublicRestriction

Register

SC070025

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel